IRIS
MAZZUCCHELLI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.550
EU - Europa 6.254
AS - Asia 6.027
SA - Sud America 1.456
Continente sconosciuto - Info sul continente non disponibili 317
AF - Africa 298
OC - Oceania 16
AN - Antartide 1
Totale 28.919
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.033
SG - Singapore 1.842
VN - Vietnam 1.171
BR - Brasile 1.159
RU - Federazione Russa 1.078
UA - Ucraina 1.022
IT - Italia 916
CN - Cina 886
DE - Germania 617
HK - Hong Kong 597
IE - Irlanda 570
TR - Turchia 554
SE - Svezia 522
DK - Danimarca 387
FR - Francia 378
FI - Finlandia 310
CA - Canada 240
GB - Regno Unito 229
KR - Corea 223
IN - India 153
BD - Bangladesh 101
AR - Argentina 99
MX - Messico 97
CI - Costa d'Avorio 89
IQ - Iraq 73
ID - Indonesia 63
ZA - Sudafrica 58
EC - Ecuador 57
JP - Giappone 56
MA - Marocco 41
PK - Pakistan 40
CO - Colombia 39
CR - Costa Rica 37
PL - Polonia 34
NL - Olanda 33
BE - Belgio 32
ES - Italia 28
SA - Arabia Saudita 27
VE - Venezuela 27
IL - Israele 25
SV - El Salvador 25
UZ - Uzbekistan 25
GT - Guatemala 24
IR - Iran 24
EG - Egitto 23
PH - Filippine 21
CL - Cile 20
MY - Malesia 20
PE - Perù 20
RO - Romania 20
CW - ???statistics.table.value.countryCode.CW??? 19
HN - Honduras 19
PY - Paraguay 18
EU - Europa 17
JO - Giordania 17
TH - Thailandia 16
TW - Taiwan 15
DZ - Algeria 14
KE - Kenya 14
SC - Seychelles 14
AT - Austria 13
JM - Giamaica 12
NI - Nicaragua 12
PR - Porto Rico 12
TT - Trinidad e Tobago 12
KZ - Kazakistan 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
AU - Australia 10
GP - Guadalupe 10
PT - Portogallo 9
UY - Uruguay 9
ET - Etiopia 8
AL - Albania 7
AZ - Azerbaigian 7
CH - Svizzera 7
GR - Grecia 7
LB - Libano 7
OM - Oman 7
BH - Bahrain 6
HU - Ungheria 6
KG - Kirghizistan 6
NP - Nepal 6
NZ - Nuova Zelanda 6
AM - Armenia 5
BO - Bolivia 5
LT - Lituania 5
NG - Nigeria 5
PA - Panama 5
AO - Angola 4
CZ - Repubblica Ceca 4
RS - Serbia 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
EE - Estonia 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
Totale 28.599
Salva come PNG Salva come JPEG
Città #
Ashburn 2.393
Singapore 1.200
Jacksonville 1.031
Chandler 976
Fairfield 758
Dallas 715
Des Moines 580
Boardman 569
Hong Kong 569
Dublin 568
Council Bluffs 532
San Jose 520
New York 406
Wilmington 402
Ho Chi Minh City 389
Woodbridge 332
Houston 288
Seattle 279
Hanoi 252
Princeton 237
The Dalles 234
Beijing 229
Lawrence 224
San Mateo 215
Cambridge 214
Lauterbourg 210
Ann Arbor 192
Moscow 154
Los Angeles 148
Centro 135
Hefei 134
São Paulo 120
Milan 101
San Diego 93
Santa Clara 90
Abidjan 89
Munich 87
Buffalo 82
Helsinki 73
Chicago 72
Haiphong 65
Da Nang 61
Rome 52
London 51
Vancouver 51
Phoenix 45
Tokyo 44
Redmond 42
Shanghai 40
Turku 39
Frankfurt am Main 37
Mexico City 36
Orem 35
Baghdad 34
Rio de Janeiro 34
Washington 34
Toronto 32
Brussels 31
Guangzhou 31
Miano 31
Montreal 30
Wuhan 30
Pune 28
San Francisco 28
Warsaw 28
Ancona 27
Atlanta 27
Belo Horizonte 27
Brooklyn 27
Chennai 26
Denver 25
Alton 24
Marche 24
Turin 24
Biên Hòa 23
Columbus 22
San José 22
Tashkent 22
Guatemala City 21
Izmir 21
San Salvador 21
Manchester 20
Hải Dương 19
Naples 19
Willemstad 19
Curitiba 18
Erbil 18
Guayaquil 18
Durban 17
Istanbul 17
Porto 17
Quito 17
Salvador 17
Johannesburg 16
Stockholm 16
Amman 15
Salt Lake City 15
Brasília 14
Campinas 14
Miami 14
Totale 17.564
Salva come PNG Salva come JPEG
Nome #
Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer 445
Metabolic phenotype of bladder cancer 272
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 230
AT-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsia 216
The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer 210
Predicting future cancer burden in the United States by artificial neural networks 206
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 198
Clinical progression of megacalycosis in a girl with a solitary kidney: The lesson learned 197
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 192
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 183
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study 183
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 178
Secondary neoplasms of the urinary system and male genital organs. 175
[Thin glomerular basement membrane disease]. 173
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 172
[Interstitial cystitis: minimal diagnostic criteria]. 171
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 166
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 166
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry 166
alpha-methylacyl-CoA racemase (P504S)/34 beta E12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy 165
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 165
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 161
Active surveillance for low-risk prostate cancer. 160
Atypical foci, suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") 160
[Nephrotic proteinuria with type 2 diabetes mellitus and autoimmune thyroiditis]. 160
Analytical and Qualitative Cytology and Histology. Reflection on the past two years. 159
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 159
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 158
Metabolic Alterations in Renal and Prostate Cancer 158
ANCA-Associated Glomerulonephritis and Anti-Phospholipid Syndrome in a Patient with SARS-CoV-2 Infection: Just a Coincidence? 158
Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT 156
Adipose cannabinoid CB1 receptor expression and adiponectin correlate with microvascular damage in human kidney 156
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 154
AT-rich interactive domain 1A (ARID1A) cannot be considered a morphological marker for prostate cancer progression: A pilot study 154
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 153
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 153
Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study 152
Angiogenesis as prognostic factor in small renal tumors 152
Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis 152
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 151
2005 update on pathology of prostate biopsies with cancer 150
PUNLMP or not PUNLMP? This is the problem. 149
Low HtrA1 expression in patients with long‑standing ulcerative colitis and colorectal cancer 149
A contemporary update on pathology reporting for urinary bladder cancer. 148
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 147
Genitourinary cancers: molecular determinants for personalized therapies 147
Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma 146
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 146
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 146
Ciliary Neurotrophic Factor Modulates Multiple Downstream Signaling Pathways in Prostate Cancer Inhibiting Cell Invasiveness 145
Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance. 143
Morphological diagnosis of urothelial neoplasms. 143
Adipose cannabinoid CBI receptor and adiponectin expression correlate with microvascular damage in human-kidney 143
A painful diagnosis 142
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 140
Epigenetic modifications and modulators in prostate cancer 140
HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker. 139
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 138
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma 138
Prognostic role of Furhman grade and vascular endothelia growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens 137
Gleason grading of prostate carcinoma in needle biopsies vs. radical prostatectomy specimens. 137
alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer 137
pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging 137
Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report 137
Dose-dependent effects of curcumin on 22Rv1 prostate cancer cell line 136
Changes in the normal-looking epithelium in prostates with PIN or cancer. 136
Pathology and molecular updates in tumors of the prostate: towards a personalized approach. 136
Increased VEGF165 expression in HCT116 colon cancer cells after transient transfection with a GFP vector encoding HIF-1 gene. 135
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 135
Renal sarcoma associated with adult polycystic kidney disease. A case report and literature review. 134
Urothelial changes induced by therapeutic procedures for bladder cancer. A review. 133
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. 133
Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies. 132
KIDNEY CANCER: NOT A SINGLE DISEASE. 131
Biphasic Tumors of the Urogenital Tract: Selected Topics 130
A magnetic resonance imaging-based nomogram for predicting clinically significant prostate cancer at radical prostatectomy 129
NRF2 modulation in TRAMP mice: an in vivo model of prostate cancer 129
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 129
[Diagnosis of Alport syndrome] 129
Pathology of prostate cancer and focal therapy ('male lumpectomy'). 128
Molecular mechanisms in prostate cancer. A review. 128
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma 127
Case diagnosis as positive identification in prostatic neoplasia 126
Re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738–9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides 126
Immunohistochemical expression of Endothelin-1 and Endothelin-A and Endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer. 125
Putative tissue markers in prostate cancer*. 125
Clinicopathological significance of lymphovascular invasion in urothelial carcinoma 125
Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? 124
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. 124
Apolipoprotein E expression in localized prostate cancers. 123
Joint appraisal of the radical prostatectomy specimen by the urologist and the uropathologist: together, we can do it better 123
Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia. 123
Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes 123
Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sections. 123
Molecular techniques and prostate cancer diagnostic. 122
Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy. 122
Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there? 121
Prostate cancer in 2021: Novelties in prognostic and therapeutic biomarker evaluation 121
Specimen orientation by marking the peripheral end: (potential) clinical advantages in prostate biopsy. 120
Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. 120
Totale 15.205
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.129
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.004 0 0 0 0 11 109 47 108 106 132 107 384
2022/20233.227 282 248 202 277 224 840 8 202 738 17 125 64
2023/20241.857 312 56 90 268 317 427 26 41 13 44 31 232
2024/20253.689 389 311 190 89 116 109 350 176 925 257 352 425
2025/20269.519 530 704 752 1.023 851 660 1.818 955 803 788 206 429
2026/20272.643 423 434 454 1.281 51 0 0 0 0 0 0 0
Totale 28.919